Ease the criteria of the health insurance reimbursement for rheumatoid arthritis drug

The government revealed a plan that would ease the criteria of the health insurance reimbursement for the drug that is used to treat rheumatoid arthritis and severe Alzheimer-type dementia, considerably impacting the sales revenue of the related products.

Recently, the MOHW (Ministry of Health and Welfare) gave notice of ‘the details of application criteria and methodology of medical care expe...